Skip to main content
SpringerLink
Log in

Pulmonale Erkrankungen

  • Chapter
Neugeborenenintensivmedizin

  • 4392 Accesses

Zusammenfassung

Die Lunge wurde als Respirationsorgan während der Fetalzeit nicht gebraucht, und die mit der Geburt einsetzende Atmung ist leicht störbar. Die häufigsten und schwerwiegendsten pulmonalen Erkrankungen des Neugeborenen sind das Atemnotsyndrom des Frühgeborenen durch Surfactantmangel, das Mekoniumaspirationssyndrom, die gehäuft nach Schnittentbindung auftretende Flüssigkeitslunge, und der Pneumothorax. Die bronchopulmonale Dysplasie ist eine chronische Lungenerkrankung des Frühgeborenen, bei deren Entstehung Unreife, Barotrauma, Sauerstoff, und persistierender Ductus arteriosus zusammenwirken.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Literatur

  1. Ardell S, Pfister RH, Soll R (2015) Animal derived surfactant extract versus protein free synthetic surfactant for the prevention and treatment of respiratory distress syndrome. Cochrane Database Syst Rev 8:CD000144

    Google Scholar 

  2. Askie LM (2013) Optimal oxygen saturations in preterm infants: a moving target. Curr Opin Pediatr 25(2):188–92

    Google Scholar 

  3. Bahadue FL, Soll R (2012) Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome. Cochrane Database Syst Rev 11:CD001456

    Google Scholar 

  4. Barrington KJ, Finer N (2010) Inhaled nitric oxide for respiratory failure in preterm infants. Cochrane Database Syst Rev (12):CD000509

    Google Scholar 

  5. Bassler D, Plavka R, Shinwell ES et al. (2015) Early inhaled budesonide for the prevention of bronchopulmonary dysplasia. N Engl J Med 373(16): 1497–506

    Google Scholar 

  6. Baud O, Foix-L’Helias L, Kaminski M et al. (1999) Antenatal glucocorticoid treatment and cystic periventricular leukomalacia in very premature infants. N Engl J Med 341(16):1190–6

    Google Scholar 

  7. Bell EF, Acarregui MJ (2014) Restricted versus liberal water intake for preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev 12:CD000503

    Google Scholar 

  8. Carlo WA, Stark AR, Wright LL et al. (2002) Minimal ventilation to prevent bronchopulmonary dysplasia in extremely-low-birth-weight infants. J Pediatr 141(3):370–4

    Google Scholar 

  9. Cole CH, Colton T, Shah BL et al. (1999) Early inhaled glucocorticoid therapy to prevent bronchopulmonary dysplasia. N Engl J Med 340(13):1005–10

    Google Scholar 

  10. Cools F, Offringa M, Askie LM (2015) Elective high frequency oscillatory ventilation versus conventional ventilation for acute pulmonary dysfunction in preterm infants. Cochrane Database Syst Rev 3:CD000104

    Google Scholar 

  11. Darlow BA, Graham PJ (2011) Vitamin A supplementation to prevent mortality and short- and long-term morbidity in very low birthweight infants. Cochrane Database Syst Rev (10):CD000501

    Google Scholar 

  12. Doyle LW, Ehrenkranz RA, Halliday HL (2014) Early (< 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants. Cochrane Database Syst Rev 5:CD001146

    Google Scholar 

  13. Doyle LW, Ehrenkranz RA, Halliday HL (2014) Late (> 7 days) postnatal corticosteroids for chronic lung disease in preterm infants. Cochrane Database Syst Rev 5:CD001145

    Google Scholar 

  14. El Shahed AI, Dargaville PA, Ohlsson A, Soll R (2014) Surfactant for meconium aspiration syndrome in term and late preterm infants. Cochrane Database Syst Rev 12:CD002054

    Google Scholar 

  15. Finer NN, Carlo WA, Walsh MC et al. (2010) Early CPAP versus surfactant in extremely preterm infants. N Engl J Med 362(21):1970–9

    Google Scholar 

  16. Flenady VJ, Gray PH (2002) Chest physiotherapy for preventing morbidity in babies being extubated from mechanical ventilation. Cochrane Database Syst Rev (2):CD000283

    Google Scholar 

  17. Fowlie PW, Davis PG, McGuire W (2010) Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants. Cochrane Database Syst Rev 7:CD000174

    Google Scholar 

  18. Gillies D, Wells D, Bhandari AP (2012) Positioning for acute respiratory distress in hospitalised infants and children. Cochrane Database Syst Rev 7:CD003645

    Google Scholar 

  19. Halliday HL (2001) Endotracheal intubation at birth for preventing morbidity and mortality in vigorous, meconium-stained infants born at term. Cochrane Database Syst Rev (1):CD000500

    Google Scholar 

  20. Ho JJ, Subramaniam P, Davis PG (2015) Continuous distending pressure for respiratory distress in preterm infants. Cochrane Database Syst Rev 7:CD002271

    Google Scholar 

  21. Jobe AH, Bancalari E (2001) Bronchopulmonary dysplasia. Am J Respir Crit Care Med 163(7):1723–9

    Google Scholar 

  22. Kanmaz HG, Erdeve O, Canpolat FE, Mutlu B, Dilmen U (2013) Surfactant administration via thin catheter during spontaneous breathing: randomized controlled trial. Pediatrics 131(2):e502–9

    Google Scholar 

  23. Kribs A, Roll C, Gopel W et al. (2015) Nonintubated surfactant application vs conventional therapy in extremely preterm infants: A randomized clinical trial. JAMA Pediatr 169(8):723–30

    Google Scholar 

  24. Liu CQ, Ma L, Tang LM et al. (2008) [A randomized controlled study on the efficacy of inhaled nitric oxide in treatment of neonates with meconium aspiration syndrome]. Zhonghua Er Ke Za Zhi 46(3):224–8

    Google Scholar 

  25. Mabanta CG, Pryhuber GS, Weinberg GA, Phelps DL (2003) Erythromycin for the prevention of chronic lung disease in intubated preterm infants at risk for, or colonized or infected with Ureaplasma urealyticum. Cochrane Database Syst Rev (4):CD003744

    Google Scholar 

  26. Nair J, Lakshminrusimha S (2014) Update on PPHN: mechanisms and treatment. Semin Perinatol 38(2):78–91

    Google Scholar 

  27. Ng G, da Silva O, Ohlsson A (2012) Bronchodilators for the prevention and treatment of chronic lung disease in preterm infants. Cochrane Database Syst Rev 6:CD003214

    Google Scholar 

  28. Ng G, Ohlsson A (2012) Cromolyn sodium for the prevention of chronic lung disease in preterm infants. Cochrane Database Syst Rev 6:CD003059

    Google Scholar 

  29. Rojas-Reyes MX, Morley CJ, Soll R (2012) Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev 3:CD000510

    Google Scholar 

  30. Seger N, Soll R (2009) Animal derived surfactant extract for treatment of respiratory distress syndrome. Cochrane Database Syst Rev (2):CD007836

    Google Scholar 

  31. Shah SS, Ohlsson A, Halliday HL, Shah VS (2012) Inhaled versus systemic corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonates. Cochrane Database Syst Rev 5:CD002058

    Google Scholar 

  32. Shah SS, Ohlsson A, Halliday HL, Shah VS (2012) Inhaled versus systemic corticosteroids for the treatment of chronic lung disease in ventilated very low birth weight preterm infants. Cochrane Database Syst Rev 5:CD002057

    Google Scholar 

  33. Soll RF, Özek E (2009) Multiple versus single dose natural surfactant extract for severe neonatal respiratory distress syndrome. Cochrane Database Syst Rev (2):CD000141

    Google Scholar 

  34. Stevens TP, Harrington EW, Blennow M, Soll RF (2007) Early surfactant administration with brief ventilation vs. selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome. Cochrane Database Syst Rev (4):CD003063

    Google Scholar 

  35. Stewart A, Brion LP, Ambrosio-Perez I (2011) Diuretics acting on the distal renal tubule for preterm infants with (or developing) chronic lung disease. Cochrane Database Syst Rev (9):CD001817

    Google Scholar 

  36. Thome UH, Ambalavanan N (2009) Permissive hypercapnia to decrease lung injury in ventilated preterm neonates. Semin Fetal Neonatal Med 14(1):21–7

    Google Scholar 

  37. Van Meurs KP, Wright LL, Ehrenkranz RA et al. (2005) Inhaled nitric oxide for premature infants with severe respiratory failure. N Engl J Med 353(1):13–22

    Google Scholar 

  38. Ward M, Sinn J (2003) Steroid therapy for meconium aspiration syndrome in newborn infants. Cochrane Database Syst Rev (4):CD003485

    Google Scholar 

  39. Woodgate PG, Davies MW (2001) Permissive hypercapnia for the prevention of morbidity and mortality in mechanically ventilated newborn infants. Cochrane Database Syst Rev (2):CD002061

    Google Scholar 

  40. Wyllie J, Perlman JM, Kattwinkel J et al. (2015) Part 7: Neonatal resuscitation: 2015 International consensus on cardiopulmonary resuscitation and emergency cardiovascular care science with treatment recommendations. Resuscitation 95:e169–201

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik für Neonatologie, Augustenburger Platz 1, 13353, Berlin

    Prof. Dr. Michael Obladen

Authors
  1. Prof. Dr. Michael Obladen
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer-Verlag GmbH Deutschland

About this chapter

Cite this chapter

Obladen, M. (2017). Pulmonale Erkrankungen. In: Neugeborenenintensivmedizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-53576-9_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-53576-9_5

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-53575-2

  • Online ISBN: 978-3-662-53576-9

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation